Investments
30Portfolio Exits
24Funds
8Partners & Customers
2Service Providers
1About Olympus Partners
Olympus Partners is a private equity firm that provides equity capital to privately held, middle-market business services, logistics, healthcare, financial services, consumer products and information technology companies. It manages corporate pension plans, public retirement systems, and university endowment funds. The company was founded in 1988 and is based in Stamford, Connecticut.
Want to inform investors similar to Olympus Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Olympus Partners News
Apr 24, 2023
Notizie da: MBK Partners, Neo Investment Partners, JP Morgan Growth Equity Partners, A&M Capital Europe, Sculptor Capital Management, Olympus Partners e altri La società di private equity MBK Partners acquisirà Pierre Marcolini, un marchio di cioccolato belga chiamato "Hermes of Chocolate". Si veda qui kedglobal. MBK ha acquistato i diritti commerciali sudcoreani, giapponesi e australiani del marchio globale di cioccolato Godiva quattro anni fa e ha pianificato di rafforzare la sua gamma di cioccolato premium aggiungendo Pierre Marcolini. Secondo fonti a conoscenza della questione mercoledì, VM2 Holdings, la filiale di investimento giapponese di MBK, ha deciso di acquistare l'intera quota del 47% di Pierre Marcolini detenuta dal fondo di investimento britannico Neo Investment Partners. Il prezzo di acquisto non è stato reso noto. Neo Investment ha acquisito una partecipazione del 47% in Pier Abbonati o Accedi per leggere il resto di questo contenuto.
Olympus Partners Investments
30 Investments
Olympus Partners has made 30 investments. Their latest investment was in Tank Holding as part of their Recap on April 4, 2022.
Olympus Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/11/2022 | Recap | Tank Holding | $1,685M | No | Antares Capital, Barings, Carlyle, ICG, and Olympus Partners | 1 |
5/22/2014 | Private Equity | Pregis North America | Yes | 1 | ||
8/11/2011 | Series D | Siva Power | $23.47M | No | 2 | |
6/17/2010 | Series C | |||||
4/24/2009 | Growth Equity |
Date | 4/11/2022 | 5/22/2014 | 8/11/2011 | 6/17/2010 | 4/24/2009 |
|---|---|---|---|---|---|
Round | Recap | Private Equity | Series D | Series C | Growth Equity |
Company | Tank Holding | Pregis North America | Siva Power | ||
Amount | $1,685M | $23.47M | |||
New? | No | Yes | No | ||
Co-Investors | Antares Capital, Barings, Carlyle, ICG, and Olympus Partners | ||||
Sources | 1 | 1 | 2 |
Olympus Partners Portfolio Exits
24 Portfolio Exits
Olympus Partners has 24 portfolio exits. Their latest portfolio exit was Petmate on September 15, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/15/2021 | Acq - Fin - III | 1 | |||
11/30/2020 | Acquired | 5 | |||
10/18/2019 | Acquired | 1 | |||
Date | 9/15/2021 | 11/30/2020 | 10/18/2019 | ||
|---|---|---|---|---|---|
Exit | Acq - Fin - III | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 5 | 1 |
Olympus Partners Acquisitions
40 Acquisitions
Olympus Partners acquired 40 companies. Their latest acquisition was International Wire Group on April 14, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
4/14/2023 | Acq - Fin | 1 | ||||
9/7/2022 | Debt | Acq - Fin - II | 10 | |||
4/29/2022 | Acq - Fin - II | 2 | ||||
3/31/2022 | ||||||
12/29/2020 | Debt |
Date | 4/14/2023 | 9/7/2022 | 4/29/2022 | 3/31/2022 | 12/29/2020 |
|---|---|---|---|---|---|
Investment Stage | Debt | Debt | |||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acq - Fin | Acq - Fin - II | Acq - Fin - II | ||
Sources | 1 | 10 | 2 |
Olympus Partners Fund History
8 Fund Histories
Olympus Partners has 8 funds, including Olympus Growth Fund VII.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/17/2017 | Olympus Growth Fund VII | Buyouts & Acquisitions | Closed | $3,040M | 2 |
6/30/2013 | Olympus Growth Fund VI LP | ||||
3/15/2008 | Olympus Debt Fund | ||||
5/1/2003 | Olympus Growth Fund IV LP | ||||
4/23/1998 | Olympus Growth Fund III LP |
Closing Date | 12/17/2017 | 6/30/2013 | 3/15/2008 | 5/1/2003 | 4/23/1998 |
|---|---|---|---|---|---|
Fund | Olympus Growth Fund VII | Olympus Growth Fund VI LP | Olympus Debt Fund | Olympus Growth Fund IV LP | Olympus Growth Fund III LP |
Fund Type | Buyouts & Acquisitions | ||||
Status | Closed | ||||
Amount | $3,040M | ||||
Sources | 2 |
Olympus Partners Partners & Customers
2 Partners and customers
Olympus Partners has 2 strategic partners and customers. Olympus Partners recently partnered with Imbio on February 2, 2021.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
2/17/2021 | Supplier | United States | CENTER VALLEY , Pa. , -LRB- February 17 , 2021 -RRB- -- Today , Olympus Partners announced a partnership with Imbio , LLC to provide physicians with the SeleCT ™ QCT analysis service to evaluate patient eligibility for treatment with the Spiration ® Valve System , an FDA-designated breakthrough device to treat severe emphysema , a form of chronic obstructive pulmonary disease -LRB- COPD -RRB- . | 1 | |
6/1/2019 | Partner |
Date | 2/17/2021 | 6/1/2019 |
|---|---|---|
Type | Supplier | Partner |
Business Partner | ||
Country | United States | |
News Snippet | CENTER VALLEY , Pa. , -LRB- February 17 , 2021 -RRB- -- Today , Olympus Partners announced a partnership with Imbio , LLC to provide physicians with the SeleCT ™ QCT analysis service to evaluate patient eligibility for treatment with the Spiration ® Valve System , an FDA-designated breakthrough device to treat severe emphysema , a form of chronic obstructive pulmonary disease -LRB- COPD -RRB- . | |
Sources | 1 |
Olympus Partners Service Providers
1 Service Provider
Olympus Partners has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Kirkland & Ellis | Acq - Fin | Counsel | General Counsel |
Service Provider | Kirkland & Ellis |
|---|---|
Associated Rounds | Acq - Fin |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
Olympus Partners Team
2 Team Members
Olympus Partners has 2 team members, including current Managing Partner, James A Conroy.
Name | Work History | Title | Status |
|---|---|---|---|
James A Conroy | Managing Partner | Current | |
Name | James A Conroy | |
|---|---|---|
Work History | ||
Title | Managing Partner | |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.